N@N

Irina Rivkind Koffler Upgraded (TEVA) to Strong Buy on, Jan 9th, 2018

^{Published on 2024-10-26 01:50:42 - WOPRAI, Irina Rivkind Koffler}
 

Irina Rivkind Koffler of Mizuho, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 9th, 2018.

Irina has made no other calls on TEVA in the last 4 months.

There are 11 other peers that have a rating on TEVA. Out of the 11 peers that are also analyzing TEVA, 5 agree with Irina's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
• Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
• Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
• Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
• Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017

These are the ratings of the 6 analyists that currently disagree with Irina

---

• Jacob Hughes of "Wells Fargo" Downgraded from Hold to Sell on, Friday, January 5th, 2018
• Liav Abraham of "Citigroup" Upgraded from Hold to Strong Buy on, Thursday, January 4th, 2018
• Ami Fadia of "Leerink Swann" Initiated at Sell and Held Target at $15 on, Tuesday, January 2nd, 2018
• Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
• Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
• Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017

Contributing Sources

---